HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yosuke Togashi Selected Research
Yosuke Togashi Research Topics
Disease
54
Neoplasms (Cancer)
10/2022 - 08/2008
41
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2010
12
Lung Neoplasms (Lung Cancer)
11/2021 - 03/2010
12
Neoplasm Metastasis (Metastasis)
04/2020 - 03/2010
8
Stomach Neoplasms (Stomach Cancer)
01/2020 - 12/2014
7
Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 05/2014
4
Melanoma (Melanoma, Malignant)
11/2021 - 01/2014
4
Adenocarcinoma of Lung
01/2020 - 02/2011
4
Pancreatic Neoplasms (Pancreatic Cancer)
06/2017 - 05/2014
3
Disease Progression
12/2020 - 05/2014
3
Lymphoma (Lymphomas)
01/2020 - 10/2014
3
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2015 - 08/2012
2
Microsatellite Instability
01/2022 - 10/2021
2
Infections
09/2021 - 08/2011
2
Exanthema (Rash)
01/2020 - 07/2013
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2016 - 08/2012
2
Diarrhea
07/2013 - 10/2011
2
Pneumonia (Pneumonitis)
07/2012 - 06/2010
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2012 - 04/2011
2
Pleural Effusion (Pleural Effusions)
09/2011 - 09/2010
2
Chronic Kidney Failure (Chronic Renal Failure)
04/2011 - 05/2010
2
Loeys-Dietz Syndrome
08/2008 - 01/2007
1
Pathologic Complete Response
01/2022
1
Rectal Neoplasms (Rectal Cancer)
01/2022
1
Breast Neoplasms (Breast Cancer)
11/2021
1
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
09/2021
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2020
1
Esophageal Squamous Cell Carcinoma
04/2020
1
Hodgkin Disease (Hodgkin's Disease)
01/2020
1
Adenocarcinoma
01/2020
1
Proteinuria
01/2020
1
Squamous Cell Carcinoma of Head and Neck
01/2016
Drug/Important Bio-Agent (IBA)
21
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 01/2010
15
Erlotinib Hydrochloride (CP 358,774)
FDA Link
06/2017 - 04/2010
12
Tyrosine Kinase Inhibitors
IBA
01/2021 - 05/2010
10
Immune Checkpoint Inhibitors
IBA
10/2022 - 01/2019
9
Gefitinib (Iressa)
FDA Link
01/2014 - 01/2010
6
Afatinib
IBA
12/2020 - 04/2015
5
Phosphotransferases (Kinase)
IBA
12/2016 - 04/2010
5
Pharmaceutical Preparations
IBA
08/2015 - 09/2011
5
Epidermal Growth Factor (EGF)
IBA
01/2014 - 04/2010
4
Ligands
IBA
01/2022 - 01/2019
4
Biomarkers (Surrogate Marker)
IBA
11/2020 - 10/2011
4
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2019 - 08/2015
4
Formaldehyde (Formol)
FDA Link
02/2015 - 02/2013
4
Paraffin
IBA
02/2015 - 02/2013
3
Nivolumab
IBA
01/2022 - 01/2020
3
Monoclonal Antibodies
IBA
01/2020 - 01/2019
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
12/2016 - 12/2014
3
OSI-420
IBA
09/2011 - 05/2010
2
Programmed Cell Death 1 Receptor
IBA
10/2022 - 11/2020
2
Catenins
IBA
11/2021 - 01/2015
2
Neoplasm Antigens (Tumor Antigens)
IBA
11/2021 - 01/2019
2
pembrolizumab
IBA
11/2020 - 01/2019
2
trametinib
IBA
08/2015 - 12/2014
2
Gemcitabine
FDA Link
07/2015 - 02/2011
2
Crizotinib
IBA
03/2015 - 10/2014
2
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
03/2015 - 10/2014
2
Activins (Activin)
IBA
01/2015 - 05/2014
2
Proteins (Proteins, Gene)
FDA Link
08/2014 - 01/2014
2
Transforming Growth Factor beta (TGF-beta)
IBA
05/2014 - 08/2008
2
Bevacizumab (Avastin)
FDA Link
05/2014 - 08/2011
2
Insulin-Like Peptides
IBA
09/2012 - 10/2011
2
Insulin-Like Growth Factor Binding Protein 3
IBA
09/2012 - 10/2011
2
Pemetrexed (MTA)
FDA Link
08/2012 - 03/2011
2
Transforming Growth Factor beta Receptors (TGF beta Receptors)
IBA
08/2008 - 01/2007
1
Glucose (Dextrose)
FDA Link
Generic
01/2022
1
Lactic Acid (Lactate)
FDA Link
Generic
01/2022
1
RNA (Ribonucleic Acid)
IBA
11/2021
1
Protein Isoforms (Isoforms)
IBA
11/2021
1
Small Cytoplasmic RNA
IBA
11/2021
1
Calcibiotic Root Canal Sealer
IBA
10/2021
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
10/2021
1
Membrane Proteins (Integral Membrane Proteins)
IBA
09/2021
1
napabucasin
IBA
11/2020
1
atezolizumab
IBA
04/2020
1
Cisplatin (Platino)
FDA Link
Generic
04/2020
1
Fluorouracil (Carac)
FDA Link
Generic
04/2020
1
HLA Antigens (Human Leukocyte Antigens)
IBA
04/2020
1
regorafenib
IBA
01/2020
1
Nonesterified Fatty Acids (NEFA)
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2019
1
Immune Checkpoint Proteins
IBA
01/2019
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2019
1
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
01/2017
1
tyrosine receptor (receptor, tyrosine)
IBA
12/2016
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
11/2016
1
nintedanib
IBA
11/2016
1
Carcinoembryonic Antigen
IBA
11/2016
1
Cetuximab (Erbitux)
FDA Link
01/2016
1
Collagen
IBA
01/2016
1
neratinib
IBA
12/2015
Therapy/Procedure
26
Therapeutics
01/2022 - 01/2010
12
Drug Therapy (Chemotherapy)
04/2020 - 09/2010
11
Immunotherapy
02/2022 - 01/2019
3
Aftercare (After-Treatment)
12/2019 - 03/2015
2
Chemoradiotherapy
01/2022 - 04/2020
2
Radiotherapy
01/2020 - 01/2015
2
Renal Dialysis (Hemodialysis)
04/2011 - 05/2010
1
Precision Medicine
01/2019